| - GRCh37:
- Chr5:88100457
- GRCh38:
- Chr5:88804640
| MEF2C | Y72* | Intellectual disability, autosomal dominant 20 | Likely pathogenic (Nov 24, 2023) | no assertion criteria provided |
| - GRCh37:
- Chr5:88024338
- GRCh38:
- Chr5:88728521
| MEF2C | M208V, M310V, M358V, M350V, M368V, M348V, M232V, M302V | Intellectual disability, autosomal dominant 20 | Uncertain significance | criteria provided, single submitter |
| - GRCh38:
- Chr5:88189536-93784597
| ADGRV1, ARB2A, ARRDC3, ARRDC3-AS1, CETN3, CRE1, LINC01339, LINC02060, LOC102724637, LOC105379082, LOC110120605, LOC110120640, LOC110120688, LOC110120699, LOC110120744, LOC110120771, LOC110120808, LOC110120815, LOC110120966, LOC110120971, LOC110120974, LOC110120977, LOC110120982, LOC110120991, LOC110121009, LOC110121012, LOC110121013, LOC110121035, LOC110121147, LOC121079950, LOC123497931, LOC123497932, LOC123497933, LOC123497934, LOC123497935, LOC123497936, LOC123497937, LOC123497938, LOC123497939, LOC126807447, LOC126807448, LOC126807449, LOC126807450, LOC126807451, LOC126807452, LOC128772265, LOC128772266, LOC128772267, LOC128772268, LOC128772269, LOC128772270, LOC128772271, LOC128772272, LOC128772273, LOC129389317, LOC129389318, LOC129389319, LOC129389320, LOC129389321, LOC129994175, LOC129994176, LOC129994177, LOC129994178, LOC129994179, LOC129994180, LOC129994181, LOC129994182, LOC129994183, LOC129994184, LOC129994185, LOC129994186, LOC129994187, LOC129994188, LOC129994189, LOC129994190, LOC129994191, LOC129994192, LOC129994193, LOC129994194, LOC129994195, LOC129994196, LOC129994197, LOC129994198, LOC129994199, LOC129994200, LOC129994201, LOC129994202, LOC129994203, LOC129994204, LOC129994205, LOC129994206, LOC129994207, LOC129994208, LOC129994209, LOC129994210, LOC129994211, LOC129994212, LOC129994213, LOC129994214, LOC129994215, LOC129994216, LOC731157, LUCAT1, LYSMD3, MBLAC2, MEF2C, MEF2C-AS1, MEF2C-AS2, MIR2277, MIR3660, MIR9-2, MIR9-2HG, NR2F1, NR2F1-AS1, POLR3G, POU5F2, TMEM161B, TMEM161B-DT | | Intellectual disability, autosomal dominant 20 | Pathogenic (Aug 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88057001
- GRCh38:
- Chr5:88761184
| MEF2C | | Intellectual disability, autosomal dominant 20 | Pathogenic (Feb 17, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100432
- GRCh38:
- Chr5:88804615
| MEF2C | N81D | Intellectual disability, autosomal dominant 20 | Pathogenic (Apr 13, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100463
- GRCh38:
- Chr5:88804646
| MEF2C | E71fs | Intellectual disability, autosomal dominant 20 | Pathogenic (May 31, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100580-88100582
- GRCh38:
- Chr5:88804763-88804765
| MEF2C | K31del | Intellectual disability, autosomal dominant 20 | Pathogenic (May 31, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100584
- GRCh38:
- Chr5:88804767
| MEF2C | K30T | Intellectual disability, autosomal dominant 20 | Likely pathogenic (May 8, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119584
- GRCh38:
- Chr5:88823767
| MEF2C | I8L | Intellectual disability, autosomal dominant 20 | Likely pathogenic (Dec 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100567
- GRCh38:
- Chr5:88804750
| MEF2C | S36R | Intellectual disability, autosomal dominant 20 | Likely pathogenic (Oct 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88047783
- GRCh38:
- Chr5:88751966
| MEF2C | | Intellectual disability, autosomal dominant 20 | Uncertain significance (Nov 6, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027632
- GRCh38:
- Chr5:88731815
| MEF2C | P100A, P116A, P194A, P240A, P242A, P260A | Intellectual disability, autosomal dominant 20 | Uncertain significance (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119563
- GRCh38:
- Chr5:88823746
| MEF2C | R15G | Intellectual disability, autosomal dominant 20 | Uncertain significance (Dec 6, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018636
- GRCh38:
- Chr5:88722819
| MEF2C, MEF2C-AS2 | H322L, H360L, H362L, H370L, T221S, T245S, T277S, T323S, T347S, T355S, T361S, T363S, T371S, T381S, T393S, T395S, T403S, T413S | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jun 18, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88056982-88119605
| MEF2C | | Intellectual disability, autosomal dominant 20 | Pathogenic (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100395-88119605
| MEF2C | | Intellectual disability, autosomal dominant 20 | Pathogenic (Sep 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100395-88100638
| MEF2C | | Intellectual disability, autosomal dominant 20 | Pathogenic (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025107
- GRCh38:
- Chr5:88729290
| MEF2C | V172I, V308I, V148I, V288I, V242I, V298I, V250I, V290I | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jul 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025184
- GRCh38:
- Chr5:88729367
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119566
- GRCh38:
- Chr5:88823749
| MEF2C | E14K | Intellectual disability, autosomal dominant 20 | Uncertain significance (Nov 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88044949
- GRCh38:
- Chr5:88749132
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88026015
- GRCh38:
- Chr5:88730198
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Feb 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100594
- GRCh38:
- Chr5:88804777
| MEF2C | G27R | Intellectual disability, autosomal dominant 20 | Likely pathogenic (Mar 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027627
- GRCh38:
- Chr5:88731810
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Sep 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027729
- GRCh38:
- Chr5:88731912
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024462-88024464
- GRCh38:
- Chr5:88728645-88728647
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Dec 16, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119540
- GRCh38:
- Chr5:88823723
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (May 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027587
- GRCh38:
- Chr5:88731770
| MEF2C | V255L, V115L, V209L, V275L, V131L, V257L | Intellectual disability, autosomal dominant 20 | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018705
- GRCh38:
- Chr5:88722888
| MEF2C | L254I, L332I, L370I, L372I, L390I, L324I, L380I | Intellectual disability, autosomal dominant 20 | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88026039
- GRCh38:
- Chr5:88730222
| MEF2C | D149H, D227H, D275H | Intellectual disability, autosomal dominant 20 | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100574
- GRCh38:
- Chr5:88804757
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88057161
- GRCh38:
- Chr5:88761344
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024373
- GRCh38:
- Chr5:88728556
| MEF2C | S298L, S338L, S220L, S336L, S346L, S356L, S196L, S290L | Intellectual disability, autosomal dominant 20 | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100545
- GRCh38:
- Chr5:88804728
| MEF2C | I43S | Intellectual disability, autosomal dominant 20 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100542
- GRCh38:
- Chr5:88804725
| MEF2C | A44E | Intellectual disability, autosomal dominant 20 | Uncertain significance (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027701
- GRCh38:
- Chr5:88731884
| MEF2C | P171T, P93T, P217T, P219T, P237T, P77T | Intellectual disability, autosomal dominant 20 | Uncertain significance (Feb 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88047658
- GRCh38:
- Chr5:88751841
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88047752
- GRCh38:
- Chr5:88751935
| MEF2C | P169S, P189S, P29S, P45S, P123S, P171S | Intellectual disability, autosomal dominant 20 | Uncertain significance (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88056983
- GRCh38:
- Chr5:88761166
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Feb 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88057162
- GRCh38:
- Chr5:88761345
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025118
- GRCh38:
- Chr5:88729301
| MEF2C | P246fs, P144fs, P168fs, P304fs, P294fs, P238fs, P284fs, P286fs | Intellectual disability, autosomal dominant 20 | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025059
- GRCh38:
- Chr5:88729242
| MEF2C | A314S, A324S, A258S, A304S, A188S, A266S, A164S, A306S | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119539
- GRCh38:
- Chr5:88823722
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027725
- GRCh38:
- Chr5:88731908
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100412
- GRCh38:
- Chr5:88804595
| MEF2C | | Intellectual disability, autosomal dominant 20 | Uncertain significance (Dec 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119546
- GRCh38:
- Chr5:88823729
| MEF2C | | Intellectual disability, autosomal dominant 20 | Uncertain significance (Dec 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024292
- GRCh38:
- Chr5:88728475
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027732
- GRCh38:
- Chr5:88731915
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027727
- GRCh38:
- Chr5:88731910
| MEF2C | | Intellectual disability, autosomal dominant 20 | Benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018607
- GRCh38:
- Chr5:88722790
| MEF2C, MEF2C-AS2 | A372T, A332T, A370T, A380T | Intellectual disability, autosomal dominant 20 | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88057101
- GRCh38:
- Chr5:88761284
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018477
- GRCh38:
- Chr5:88722660
| MEF2C, MEF2C-AS2 | E376*, E400*, E434*, E414*, E446*, E274*, E330*, E456*, E298*, E408*, E416*, E424*, E448*, E466* | Intellectual disability, autosomal dominant 20 | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024422
- GRCh38:
- Chr5:88728605
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Nov 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024354
- GRCh38:
- Chr5:88728537
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Jul 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018542
- GRCh38:
- Chr5:88722725
| MEF2C, MEF2C-AS2 | S252N, S412N, S424N, S378N, S394N, S402N, S426N, S434N, S308N, S354N, S276N, S386N, S392N, S444N | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jul 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88057098
- GRCh38:
- Chr5:88761281
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024410-88024411
- GRCh38:
- Chr5:88728593-88728594
| MEF2C | S344fs, S184fs, S208fs, S278fs, S324fs, S334fs, S286fs, S326fs | Intellectual disability, autosomal dominant 20 | Pathogenic (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88047824
- GRCh38:
- Chr5:88752007
| MEF2C | I147V, I21V, I99V, I5V, I145V, I165V | Intellectual disability, autosomal dominant 20 | Benign (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88047722
- GRCh38:
- Chr5:88751905
| MEF2C | S179G, S199G, S39G, S133G, S181G, S55G | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88047795
- GRCh38:
- Chr5:88751978
| MEF2C | Y155fs, Y15fs, Y109fs, Y175fs, Y157fs, Y31fs | Intellectual disability, autosomal dominant 20 | Pathogenic (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018541
- GRCh38:
- Chr5:88722724
| MEF2C, MEF2C-AS2 | | Intellectual disability, autosomal dominant 20 | Likely benign (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100582
- GRCh38:
- Chr5:88804765
| MEF2C | K31E | Intellectual disability, autosomal dominant 20 | Uncertain significance (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88044886
- GRCh38:
- Chr5:88749069
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely pathogenic (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119555
- GRCh38:
- Chr5:88823738
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88047874
- GRCh38:
- Chr5:88752057
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027717
- GRCh38:
- Chr5:88731900
| MEF2C | | Intellectual disability, autosomal dominant 20 | Pathogenic (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024405
- GRCh38:
- Chr5:88728588
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Feb 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025144
- GRCh38:
- Chr5:88729327
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027606
- GRCh38:
- Chr5:88731789
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88044929
- GRCh38:
- Chr5:88749112
| MEF2C | L199V, L151V, L197V, L73V, L217V, L57V | Intellectual disability, autosomal dominant 20 | Uncertain significance (Feb 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018502
- GRCh38:
- Chr5:88722685
| MEF2C, MEF2C-AS2 | | Intellectual disability, autosomal dominant 20 | Likely benign (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018704
- GRCh38:
- Chr5:88722887
| MEF2C | L332H, L372H, L390H, L254H, L324H, L370H, L380H | Intellectual disability, autosomal dominant 20 | Uncertain significance (Dec 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018490
- GRCh38:
- Chr5:88722673
| MEF2C, MEF2C-AS2 | | Intellectual disability, autosomal dominant 20 | Likely benign (Aug 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88044938
- GRCh38:
- Chr5:88749121
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88057059
- GRCh38:
- Chr5:88761242
| MEF2C | D115E | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100632
- GRCh38:
- Chr5:88804815
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Mar 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100415
- GRCh38:
- Chr5:88804598
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely pathogenic (Oct 19, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025059-88025060
- GRCh38:
- Chr5:88729242-88729243
| MEF2C | A164fs, A188fs, A258fs, A266fs, A304fs, A306fs, A314fs, A324fs | Intellectual disability, autosomal dominant 20 | Pathogenic (Jun 11, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025091
- GRCh38:
- Chr5:88729274
| MEF2C | L153fs, L177fs, L247fs, L255fs, L293fs, L295fs, L303fs, L313fs | Intellectual disability, autosomal dominant 20 | Pathogenic (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027610
- GRCh38:
- Chr5:88731793
| MEF2C | N107S, N123S, N201S, N247S, N249S, N267S | Intellectual disability, autosomal dominant 20 | Uncertain significance (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119553
- GRCh38:
- Chr5:88823736
| MEF2C | Q18R | Intellectual disability, autosomal dominant 20 | Uncertain significance (Sep 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025080
- GRCh38:
- Chr5:88729263
| MEF2C | G157R, G181R, G251R, G259R, G297R, G299R, G307R, G317R | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88057084
- GRCh38:
- Chr5:88761267
| MEF2C | V107A | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jul 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88625195-90796047
| ADGRV1, ARRDC3, CETN3, LUCAT1, LYSMD3, MBLAC2, MEF2C, POLR3G | | Intellectual disability, autosomal dominant 20 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025166
- GRCh38:
- Chr5:88729349
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88065061-88406446
| MEF2C | | Intellectual disability, autosomal dominant 20 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr5:88119562
- GRCh38:
- Chr5:88823745
| MEF2C | R15P | Intellectual disability, autosomal dominant 20 | Pathogenic (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100569
- GRCh38:
- Chr5:88804752
| MEF2C | L35P | Intellectual disability, autosomal dominant 20 | Conflicting interpretations of pathogenicity (Aug 6, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:88145534
- GRCh38:
- Chr5:88849717
| MEF2C | | Intellectual disability, autosomal dominant 20 | Uncertain significance (Jun 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88025063
- GRCh38:
- Chr5:88729246
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100401
- GRCh38:
- Chr5:88804584
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88027711
- GRCh38:
- Chr5:88731894
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018625
- GRCh38:
- Chr5:88722808
| MEF2C-AS2, MEF2C | E326*, E364*, E366*, E374* | Intellectual disability, autosomal dominant 20 | Likely benign (Sep 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88100401-88100402
- GRCh38:
- Chr5:88804584-88804585
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Mar 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88018547
- GRCh38:
- Chr5:88722730
| MEF2C, MEF2C-AS2 | | Intellectual disability, autosomal dominant 20 | Likely benign (Sep 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119576
- GRCh38:
- Chr5:88823759
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Jan 19, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88119539
- GRCh38:
- Chr5:88823722
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024396
- GRCh38:
- Chr5:88728579
| MEF2C | | Intellectual disability, autosomal dominant 20 | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024380
- GRCh38:
- Chr5:88728563
| MEF2C | L194F, L218F, L288F, L296F, L334F, L336F, L344F, L354F | Intellectual disability, autosomal dominant 20 | Likely benign (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:88024304
- GRCh38:
- Chr5:88728487
| MEF2C | | Intellectual disability, autosomal dominant 20 | Benign (Sep 6, 2022) | criteria provided, single submitter |